المؤلفون: Carrero JJ; Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: juan.jesus.carrero@ki.se., Varenhorst C; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Jensevik K; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Szummer K; Division of Cardiology, Karolinska Institutet, Stockholm, Sweden., Lagerqvist B; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Evans M; Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden., Spaak J; Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden., Held C; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., James S; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Jernberg T; Division of Cardiology, Karolinska Institutet, Stockholm, Sweden.

المصدر: Kidney international [Kidney Int] 2017 Jan; Vol. 91 (1), pp. 216-226. Date of Electronic Publication: 2016 Nov 16.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1755 (Electronic) Linking ISSN: 00852538 NLM ISO Abbreviation: Kidney Int Subsets: MEDLINE

مواضيع طبية MeSH: Acute Coronary Syndrome/*drug therapy , Hemorrhage/*epidemiology , Myocardial Infarction/*prevention & control , Platelet Aggregation Inhibitors/*therapeutic use , Renal Insufficiency, Chronic/*complications , Stroke/*prevention & control, Acute Coronary Syndrome/blood ; Acute Coronary Syndrome/complications ; Acute Coronary Syndrome/mortality ; Aged ; Aged, 80 and over ; Aspirin/administration & dosage ; Aspirin/adverse effects ; Aspirin/therapeutic use ; Clopidogrel ; Creatinine/blood ; Drug Therapy, Combination ; Female ; Glomerular Filtration Rate ; Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Myocardial Infarction/epidemiology ; Myocardial Infarction/etiology ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Prospective Studies ; Registries ; Renal Insufficiency, Chronic/blood ; Renal Insufficiency, Chronic/mortality ; Risk Assessment ; Stroke/epidemiology ; Stroke/etiology ; Ticlopidine/administration & dosage ; Ticlopidine/adverse effects ; Ticlopidine/analogs & derivatives ; Ticlopidine/therapeutic use ; Time Factors ; Treatment Outcome